Literature DB >> 21159651

Regulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotype.

Katharine M Hardy1, Dawn A Kirschmann, Elisabeth A Seftor, Naira V Margaryan, Lynne-Marie Postovit, Luigi Strizzi, Mary J C Hendrix.   

Abstract

Metastatic melanoma is an aggressive skin cancer associated with poor prognosis. The reactivation of the embryonic morphogen Nodal in metastatic melanoma has previously been shown to regulate the aggressive behavior of these tumor cells. During the establishment of left-right asymmetry in early vertebrate development, Nodal expression is specifically regulated by a Notch signaling pathway. We hypothesize that a similar relationship between Notch and Nodal may be reestablished in melanoma. In this study, we investigate whether cross talk between the Notch and Nodal pathways can explain the reactivation of Nodal in aggressive metastatic melanoma cells. We show a molecular link between Notch and Nodal signaling in the aggressive melanoma cell line MV3 via the activity of an RBPJ-dependent Nodal enhancer element. We show a precise correlation between Notch4 and Nodal expression in multiple aggressive cell lines but not poorly aggressive cell lines. Surprisingly, Notch4 is specifically required for expression of Nodal in aggressive cells and plays a vital role both in the balance of cell growth and in the regulation of the aggressive phenotype. In addition, Notch4 function in vasculogenic mimicry and anchorage-independent growth in vitro is due in part to Notch4 regulation of Nodal. This study identifies an important role for cross talk between Notch4 and Nodal in metastatic melanoma, placing Notch4 upstream of Nodal, and offers a potential molecular target for melanoma therapy. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21159651      PMCID: PMC3057934          DOI: 10.1158/0008-5472.CAN-10-0705

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

Review 1.  The Notch signaling pathway: transcriptional regulation at Notch target genes.

Authors:  T Borggrefe; F Oswald
Journal:  Cell Mol Life Sci       Date:  2009-05       Impact factor: 9.261

2.  Expression of the embryonic morphogen Nodal in cutaneous melanocytic lesions.

Authors:  Limin Yu; Paul W Harms; Pedram Pouryazdanparast; David Sl Kim; Linglei Ma; Douglas R Fullen
Journal:  Mod Pathol       Date:  2010-05-21       Impact factor: 7.842

3.  TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells.

Authors:  Daylon James; Ariel J Levine; Daniel Besser; Ali Hemmati-Brivanlou
Journal:  Development       Date:  2005-02-09       Impact factor: 6.868

4.  Expression of nodal signalling components in cycling human endometrium and in endometrial cancer.

Authors:  Irene Papageorgiou; Peter K Nicholls; Fang Wang; Martin Lackmann; Yogeshwar Makanji; Lois A Salamonsen; David M Robertson; Craig A Harrison
Journal:  Reprod Biol Endocrinol       Date:  2009-10-29       Impact factor: 5.211

5.  Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells.

Authors:  Lynne-Marie Postovit; Naira V Margaryan; Elisabeth A Seftor; Dawn A Kirschmann; Alina Lipavsky; William W Wheaton; Daniel E Abbott; Richard E B Seftor; Mary J C Hendrix
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

Review 6.  Development and cancer: at the crossroads of Nodal and Notch signaling.

Authors:  Luigi Strizzi; Katharine M Hardy; Elisabeth A Seftor; Fabricio F Costa; Dawn A Kirschmann; Richard E B Seftor; Lynne-Marie Postovit; Mary J C Hendrix
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

7.  Notch1 is an effector of Akt and hypoxia in melanoma development.

Authors:  Barbara Bedogni; James A Warneke; Brian J Nickoloff; Amato J Giaccia; Marianne Broome Powell
Journal:  J Clin Invest       Date:  2008-10-16       Impact factor: 14.808

8.  Active Notch1 confers a transformed phenotype to primary human melanocytes.

Authors:  Chelsea C Pinnix; John T Lee; Zhao-Jun Liu; Ronan McDaid; Klara Balint; Levi J Beverly; Patricia A Brafford; Min Xiao; Benjamin Himes; Susan E Zabierowski; Yumi Yashiro-Ohtani; Katherine L Nathanson; Ana Bengston; Pamela M Pollock; Ashani T Weeraratna; Brian J Nickoloff; Warren S Pear; Anthony J Capobianco; Meenhard Herlyn
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

9.  Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Kyle W Jackson; Erin McNicholas; Mari J Kawamura; Wissam M Abdallah; Max S Wicha
Journal:  Breast Cancer Res       Date:  2004-08-16       Impact factor: 6.466

10.  Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.

Authors:  Hannah Harrison; Gillian Farnie; Sacha J Howell; Rebecca E Rock; Spyros Stylianou; Keith R Brennan; Nigel J Bundred; Robert B Clarke
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

View more
  60 in total

Review 1.  Tissue-specific homing of immune cells in malignant skin tumors.

Authors:  Hajnalka Jókai; Márta Marschalkó; Judit Csomor; József Szakonyi; Orsolya Kontár; Gábor Barna; Sarolta Kárpáti; Péter Holló
Journal:  Pathol Oncol Res       Date:  2012-04-24       Impact factor: 3.201

2.  Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications.

Authors:  Dawn A Kirschmann; Elisabeth A Seftor; Katharine M Hardy; Richard E B Seftor; Mary J C Hendrix
Journal:  Clin Cancer Res       Date:  2012-04-02       Impact factor: 12.531

3.  The involvement of Notch signaling in melanoma vasculogenic mimicry.

Authors:  Amalia Vartanian; Galina Gatsina; Irina Grigorieva; Elico Solomko; Vladislav Dombrovsky; Anatoly Baryshnikov; Eugenia Stepanova
Journal:  Clin Exp Med       Date:  2012-05-25       Impact factor: 3.984

4.  A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.

Authors:  K Zhang; P Wong; L Zhang; B Jacobs; E C Borden; J C Aster; B Bedogni
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

5.  Melanoma spheroid formation involves laminin-associated vasculogenic mimicry.

Authors:  Allison R Larson; Chung-Wei Lee; Cecilia Lezcano; Qian Zhan; John Huang; Andrew H Fischer; George F Murphy
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

6.  Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.

Authors:  Katharine M Hardy; Luigi Strizzi; Naira V Margaryan; Kanika Gupta; George F Murphy; Richard A Scolyer; Mary J C Hendrix
Journal:  Mol Cancer Res       Date:  2015-03-12       Impact factor: 5.852

7.  Plasticity underlies tumor progression: role of Nodal signaling.

Authors:  Thomas M Bodenstine; Grace S Chandler; Richard E B Seftor; Elisabeth A Seftor; Mary J C Hendrix
Journal:  Cancer Metastasis Rev       Date:  2016-03       Impact factor: 9.264

8.  The effect of bevacizumab on human malignant melanoma cells with functional VEGF/VEGFR2 autocrine and intracrine signaling loops.

Authors:  Una Adamcic; Karolina Skowronski; Craig Peters; Jodi Morrison; Brenda L Coomber
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

Review 9.  Beyond TGFβ: roles of other TGFβ superfamily members in cancer.

Authors:  Lalage M Wakefield; Caroline S Hill
Journal:  Nat Rev Cancer       Date:  2013-05       Impact factor: 60.716

10.  Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway.

Authors:  Wenchen Gong; Baocun Sun; Xiulan Zhao; Danfang Zhang; Junying Sun; Tieju Liu; Qiang Gu; Xueyi Dong; Fang Liu; Yong Wang; Xian Lin; Yanlei Li
Journal:  Oncotarget       Date:  2016-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.